Global Health Experts Warn of Rising Antifungal Resistance Threat
Infectious disease experts worldwide are raising alarms over a growing resistance to antifungal drugs, a concern highlighted in a recent publication in Nature Medicine. Led by Paul Verweij from Radboud University Medical Centre, the group of over 50 researchers is advocating for the inclusion of antifungal resistance in global antimicrobial resistance (AMR) strategies, which have traditionally focused on bacterial and viral infections. The experts have proposed a five-step plan to address this issue, emphasizing the need for increased awareness, improved surveillance, and investment in new diagnostics and treatments. The rise of drug-resistant fungi, such as Candida auris and Aspergillus fumigatus, poses significant health risks, particularly in vulnerable populations. The experts warn that without integrating antifungal resistance into the 2026 Global Action Plan on AMR, the world risks repeating past mistakes made with antibacterial resistance. 
